Multiple Roles for the Endocannabinoid System During the Earliest Stages of Life: Pre‐ and Postnatal Development
- 17 April 2008
- journal article
- review article
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 20 (s1), 75-81
- https://doi.org/10.1111/j.1365-2826.2008.01670.x
Abstract
The endocannabinoid system, including its receptors (CB(1) and CB(2)), endogenous ligands ('endocannabinoids'), synthesising and degrading enzymes, as well as transporter molecules, has been detected from the earliest stages of embryonic development and throughout pre- and postnatal development. In addition, the endocannabinoids, notably 2-arachidonyl glycerol, are also present in maternal milk. During three distinct developmental stages (i.e. embryonic implantation, prenatal brain development and postnatal suckling), the endocannabinoid system appears to play an essential role for development and survival. Thus, during early pregnancy, successful embryonic passage through the oviduct and implantation into the uterus both require critical enzymatic control of optimal anandamide levels at the appropriate times and sites. During foetal life, the cannabinoid CB(1) receptor plays a major role in brain development, regulating neural progenitor differentiation into neurones and glia and guiding axonal migration and synaptogenesis. Postnatally, CB(1) receptor blockade interferes with the initiation of milk suckling in mouse pups, by inducing oral motor weakness, which exposes a critical role for CB(1) receptors in the initiation of milk suckling by neonates, possibly by interfering with innervation of the tongue muscles. Manipulating the endocannabinoid system by pre- and/or postnatal administration of cannabinoids or maternal marijuana consumption, has significant, yet subtle effects on the offspring. Thus, alterations in the dopamine, GABA and endocannabinoid systems have been reported while enhanced drug seeking behaviour and impaired executive (prefrontal cortical) function have also been observed. The relatively mild nature of the disruptive effects of prenatal cannabinoids may be understood in the framework of the intricate timing requirements and frequently biphasic effects of the (endo)cannabinoids. In conclusion, the endocannabinoid system plays several key roles in pre- and postnatal development. Future studies should further clarify the mechanisms involved and provide a better understanding of the adverse effects of prenatal exposure, in order to design strategies for the treatment of conditions such as infertility, mental retardation and failure-to-thrive.Keywords
This publication has 49 references indexed in Scilit:
- Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantationProstaglandins & Other Lipid Mediators, 2007
- Fatty acid amide hydrolase deficiency limits early pregnancy eventsJCI Insight, 2006
- Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertilityMolecular Human Reproduction, 2005
- Effects of prenatal marijuana on response inhibition: an fMRI study of young adultsNeurotoxicology and Teratology, 2004
- Anandamide hydrolase: a guardian angel of human reproduction?Trends in Pharmacological Sciences, 2004
- Endocannabinoids in the central nervous system-an overviewProstaglandins, Leukotrienes & Essential Fatty Acids, 2002
- Autoradiographic Study of Pre- and Postnatal Distribution of Cannabinoid Receptors in Human BrainNeuroImage, 2001
- Developmental aspects of anandamide: ontogeny of response and prenatal exposurePsychoneuroendocrinology, 1996
- Presence of cannabinoid binding sites in the brain from early postnatal agesNeuroReport, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992